ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Tevogen Bio Holdings
4.37
-0.3950
-8.30%
盤後:
4.37
0.0000
0.00%
19:19 EDT
成交量:
3.96萬
成交額:
17.60萬
市值:
1,759.29萬
市盈率:
-0.46
高:
4.99
開:
4.89
低:
4.18
收:
4.76
52周最高:
75.50
52周最低:
4.18
股本:
403.04萬
流通股本:
50.72萬
量比:
0.92
換手率:
7.80%
股息:
- -
股息率:
- -
每股收益(TTM):
-9.4069
每股收益(LYR):
-3.5022
淨資產收益率:
--
總資產收益率:
-439.67%
市淨率:
-1.06
市盈率(LYR):
-1.25
資料載入中...
總覽
公司
新聞資訊
公告
Tevogen Bio Holdings:新業務機遇預計每年貢獻超2000萬美元收入 明年起助推兩位數增長
美股速递
·
昨天
Tevogen推進戰略CRO評估,拓展臨床研究交付能力並驅動收入增長
美股速递
·
昨天
BUZZ--美股走勢-Kyivstar 集團、應用材料公司、泰沃基因生物公司
路透中文
·
03/14
BUZZ-人工智能平台升級推動藥物研發,Tevogen 公司業績上升
路透中文
·
03/14
Tevogen.AI 宣佈 Predictcell™ Beta 版取得新進展,精準度指標提升並擴展專有AI基礎設施
美股速递
·
03/14
Tevogen Bio Holdings 評估收購 Sciometrix 及 Clinicus 平台以監測長期新冠症狀
美股速递
·
03/12
Tevogen Bio Holdings Inc.盤中異動 快速跳水5.01%
市场透视
·
03/11
Tevogen推進仿製藥戰略,簽署意向書評估收購Apozeal製藥的潛在可能
美股速递
·
03/06
Tevogen Bio Holdings Inc 正積極考慮其他交易,重點聚焦生命科學相關業務
美股速递
·
03/06
BUZZ-Tevogen因計劃收購數字醫療公司Sciometrix多數股權而上漲
路透中文
·
02/26
Tevogen Bio Holdings簽署意向書 擬評估收購Sciometrix及其數字護理管理平台Clinicus
美股速递
·
02/26
Tevogen Bio Holdings Inc.盤中異動 股價大漲6.06%報0.294美元
市场透视
·
02/20
Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌5.20%報0.332美元
市场透视
·
01/26
Tevogen Bio Holdings Inc.盤中異動 快速上漲6.10%報0.411美元
市场透视
·
2025/11/18
Tevogen宣佈重大臨床里程碑:擴展其針對急性和長期新冠的精準T細胞治療的HLA覆蓋範圍
美股速递
·
2025/11/06
Tevogen Bio Holdings Inc.盤中異動 下午盤急速跳水5.44%
市场透视
·
2025/11/05
Tevogen計劃與政府倡議、長期新冠患者組織及醫療服務提供者合作,加快Tvgn 489的開發
美股速递
·
2025/10/16
Tevogen Bio Holdings Inc.盤中異動 快速下挫5.39%
市场透视
·
2025/10/03
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TVGN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":4.365,"timestamp":1774641600000,"preClose":4.76,"halted":0,"volume":39567,"hourTrading":{"tag":"盘后","latestPrice":4.365,"preClose":4.365,"latestTime":"19:19 EDT","volume":196,"amount":853.73,"timestamp":1774653541068,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08298319327731084,"floatShares":507234,"shares":4030445,"eps":-9.40695,"marketStatus":"休市中","change":-0.395,"latestTime":"03-27 16:00:00 EDT","open":4.89,"high":4.99,"low":4.18,"amount":175971.6764718,"amplitude":0.170168,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.40695,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.76,"preHourTrading":{"tag":"盘前","latestPrice":5.02,"preClose":4.76,"latestTime":"08:50 EDT","volume":575,"amount":2812.569375,"timestamp":1774615817118,"change":0.26,"changeRate":0.054622,"amplitude":0.069328},"postHourTrading":{"tag":"盘后","latestPrice":4.365,"preClose":4.365,"latestTime":"19:19 EDT","volume":196,"amount":853.73,"timestamp":1774653541068,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.917806},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":507234,"roa":"-439.67%","roe":"--","lyrEps":-3.50225,"volumeRatio":0.917806,"shares":4030445,"dividePrice":0,"high":4.99,"amplitude":0.170168,"preClose":4.76,"low":4.18,"week52Low":4.18,"pbRate":"-1.06","week52High":75.5,"institutionHeld":0,"latestPrice":4.365,"eps":-9.40695,"divideRate":0,"volume":39567,"delay":0,"ttmEps":-9.40695,"open":4.89,"prevYearClose":16.555,"prevWeekClose":5.22,"prevMonthClose":13.21,"prevQuarterClose":16.555,"fiveDayClose":5.22,"twentyDayClose":13.21,"sixtyDayClose":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-06","symbol":"TVGN","defaultRemindTime":1772807400000,"type":"split","dateTimestamp":1772773200000,"forFactor":50,"toFactor":1,"ratio":50},{"market":"US","date":"2025-11-14","symbol":"TVGN","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2025-08-14","symbol":"TVGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-14","symbol":"TVGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-15","symbol":"TVGN","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1772683200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2026-03-26","current":-0.464019,"percent":0.998016,"low":-87.683882,"twenty":-26.097145,"median":-6.812932,"eighty":-2.782467,"high":-0.674235,"avg":-14.648201,"sd":15.222227,"marketCap":20970354},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367},{"date":"2025-05-02","current":-13.10675,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"marketCap":179921334},{"date":"2025-05-09","current":-14.601755,"twenty":-32.722315,"median":-21.231576,"eighty":-7.830197,"marketCap":200443841},{"date":"2025-05-16","current":-5.980818,"twenty":-32.552659,"median":-20.228412,"eighty":-7.830197,"marketCap":211477447},{"date":"2025-05-23","current":-6.396875,"twenty":-32.510851,"median":-19.566511,"eighty":-7.465051,"marketCap":226188922},{"date":"2025-05-30","current":-6.968954,"twenty":-32.378153,"median":-18.686729,"eighty":-7.414206,"marketCap":246417200},{"date":"2025-06-06","current":-7.333003,"twenty":-32.156991,"median":-18.297627,"eighty":-7.218412,"marketCap":259289740},{"date":"2025-06-13","current":-6.604904,"twenty":-32.068526,"median":-17.743768,"eighty":-7.033891,"marketCap":233544659},{"date":"2025-06-20","current":-6.240854,"twenty":-31.997175,"median":-17.550785,"eighty":-6.875341,"marketCap":220672119},{"date":"2025-06-27","current":-6.155194,"twenty":-31.696105,"median":-17.17025,"eighty":-6.729721,"marketCap":217643250},{"date":"2025-07-03","current":-6.46817,"twenty":-31.405039,"median":-16.307839,"eighty":-6.667312,"marketCap":228709856},{"date":"2025-07-11","current":-6.682997,"twenty":-31.405039,"median":-15.62498,"eighty":-6.591513,"marketCap":236305988},{"date":"2025-07-18","current":-6.792554,"twenty":-31.391273,"median":-15.003822,"eighty":-6.576385,"marketCap":240179856},{"date":"2025-07-25","current":-5.861317,"twenty":-31.327857,"median":-14.601755,"eighty":-6.518995,"marketCap":207251973},{"date":"2025-08-01","current":-5.419253,"twenty":-31.139644,"median":-14.400813,"eighty":-6.46817,"marketCap":191620913},{"date":"2025-08-08","current":-4.760814,"twenty":-30.52039,"median":-14.230663,"eighty":-6.437906,"marketCap":168338962},{"date":"2025-08-15","current":-6.178593,"twenty":-30.431925,"median":-14.065911,"eighty":-6.351294,"marketCap":192770965},{"date":"2025-08-22","current":-5.701959,"twenty":-30.042206,"median":-13.93195,"eighty":-6.299316,"marketCap":177900062},{"date":"2025-08-29","current":-5.69061,"twenty":-29.890394,"median":-13.807282,"eighty":-6.244587,"marketCap":177545993},{"date":"2025-09-05","current":-5.543711,"twenty":-29.856904,"median":-13.784336,"eighty":-6.173255,"marketCap":172962765},{"date":"2025-09-12","current":-5.571452,"twenty":-29.856904,"median":-13.664028,"eighty":-6.13684,"marketCap":173828267},{"date":"2025-09-19","current":-5.1793,"twenty":-29.856904,"median":-13.535379,"eighty":-6.076457,"marketCap":161593212},{"date":"2025-09-26","current":-4.949179,"twenty":-29.649623,"median":-13.530067,"eighty":-5.980818,"marketCap":154413477},{"date":"2025-10-03","current":-4.913873,"twenty":-29.635741,"median":-13.396106,"eighty":-5.916096,"marketCap":153311929},{"date":"2025-10-10","current":-4.653489,"twenty":-29.635741,"median":-13.224454,"eighty":-5.861317,"marketCap":145188009},{"date":"2025-10-17","current":-4.550723,"twenty":-29.193417,"median":-13.114788,"eighty":-5.799682,"marketCap":141981717},{"date":"2025-10-24","current":-4.009781,"twenty":-29.008833,"median":-12.942716,"eighty":-5.720783,"marketCap":125104422},{"date":"2025-10-31","current":-3.785965,"twenty":-28.972255,"median":-12.845429,"eighty":-5.69061,"marketCap":118121392},{"date":"2025-11-07","current":-2.958159,"twenty":-28.972255,"median":-12.617854,"eighty":-5.578387,"marketCap":92294017},{"date":"2025-11-14","current":-2.801172,"twenty":-28.52993,"median":-12.480725,"eighty":-5.543081,"marketCap":87396061},{"date":"2025-11-21","current":-2.645367,"twenty":-28.52993,"median":-12.36199,"eighty":-5.481138,"marketCap":82118544},{"date":"2025-11-28","current":-2.823943,"twenty":-28.353,"median":-12.322891,"eighty":-5.461498,"marketCap":87661993},{"date":"2025-12-05","current":-2.699132,"twenty":-28.308768,"median":-12.068752,"eighty":-5.409064,"marketCap":83787539},{"date":"2025-12-12","current":-2.752257,"twenty":-28.131838,"median":-11.442028,"eighty":-5.291239,"marketCap":85436666},{"date":"2025-12-19","current":-2.436707,"twenty":-28.02218,"median":-10.752057,"eighty":-5.153265,"marketCap":75641252},{"date":"2025-12-26","current":-2.533996,"twenty":-27.789498,"median":-9.196745,"eighty":-5.02307,"marketCap":78661339},{"date":"2026-01-02","current":-2.119238,"twenty":-27.645281,"median":-8.929381,"eighty":-4.949936,"marketCap":65786232},{"date":"2026-01-09","current":-2.496233,"twenty":-27.556816,"median":-8.756889,"eighty":-4.820059,"marketCap":77489069},{"date":"2026-01-16","current":-2.089155,"twenty":-27.424119,"median":-7.962008,"eighty":-4.663072,"marketCap":64852390},{"date":"2026-01-23","current":-2.37218,"twenty":-27.424119,"median":-7.830197,"eighty":-4.518443,"marketCap":73638158},{"date":"2026-01-30","current":-1.936804,"twenty":-27.379887,"median":-7.468419,"eighty":-4.421855,"marketCap":60123058},{"date":"2026-02-06","current":-1.818364,"twenty":-27.114492,"median":-7.46112,"eighty":-4.143606,"marketCap":56446391},{"date":"2026-02-13","current":-1.687878,"twenty":-26.7164,"median":-7.443187,"eighty":-3.975483,"marketCap":52395793},{"date":"2026-02-20","current":-1.94106,"twenty":-26.53947,"median":-7.370735,"eighty":-3.883057,"marketCap":60255162},{"date":"2026-02-27","current":-1.878738,"twenty":-26.53947,"median":-7.288685,"eighty":-3.499732,"marketCap":58320548},{"date":"2026-03-06","current":-1.006884,"twenty":-26.53947,"median":-7.128179,"eighty":-2.963203,"marketCap":31256100},{"date":"2026-03-13","current":-0.832034,"twenty":-26.318308,"median":-6.980165,"eighty":-2.886029,"marketCap":25828351},{"date":"2026-03-20","current":-0.692493,"twenty":-26.097145,"median":-6.902112,"eighty":-2.807942,"marketCap":21496637},{"date":"2026-03-26","current":-0.675539,"twenty":-26.097145,"median":-6.812932,"eighty":-2.782467,"marketCap":20970354}],"updateTime":1774678464684},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1179355179","title":"Tevogen Bio Holdings:新業務機遇預計每年貢獻超2000萬美元收入 明年起助推兩位數增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1179355179","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179355179?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 00:48","pubTimestamp":1774543689,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings宣布其新业务线预计将带来显著财务贡献,年收入有望增加超过2000万美元。这一增长动力预计将从明年开始,持续推动公司实现两位数的高增速扩张。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"1141813665","title":"Tevogen推進戰略CRO評估,拓展臨床研究交付能力並驅動收入增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1141813665","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141813665?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 00:47","pubTimestamp":1774543631,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings(简称Tevogen)正积极推进其战略性的合同研究组织(CRO)评估进程,旨在进一步扩展公司的临床研究服务交付能力,并为持续的收入增长注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2619114050","title":"BUZZ--美股走勢-Kyivstar 集團、應用材料公司、泰沃基因生物公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2619114050","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619114050?lang=zh_tw&edition=fundamental","pubTime":"2026-03-14 01:55","pubTimestamp":1773424551,"startTime":"0","endTime":"0","summary":"标普500指数.SPX下跌0.27%,报6,654.55点;纳斯达克综合指数.IXIC下跌0.65%,报22,166.50点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL4S4011HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OFRM","WDCX","SDHC","KLC","INMD","PODD","SVCO","AMPY","CCUP","RJF","TVGN","KLAR","ISPC","LVWR","INDV","CVNX","IBG","ICRC","ESQ","KYIV","CMCT","CRCA","DOUG","VEON","IMM.AU","CVNY","HBAN","BIAF","CRVS","ULTA","CRCO","BW","AIFF","FITB","PAR","SANA","AMAT","ADBG","CRCD","CVNA","VACH","ARES"],"gpt_icon":1},{"id":"2619811167","title":"BUZZ-人工智能平台升級推動藥物研發,Tevogen 公司業績上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2619811167","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619811167?lang=zh_tw&edition=fundamental","pubTime":"2026-03-14 00:43","pubTimestamp":1773420239,"startTime":"0","endTime":"0","summary":"BUZZ-人工智能平台升级推动药物研发,Tevogen 公司业绩上升3月13日 - ** 生物技术公司Tevogen Bio TVGN.O的股价在午后交易中最高上涨7.9%,至6.87美元。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL4S4011FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"1165653461","title":"Tevogen.AI 宣佈 Predictcell™ Beta 版取得新進展,精準度指標提升並擴展專有AI基礎設施","url":"https://stock-news.laohu8.com/highlight/detail?id=1165653461","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165653461?lang=zh_tw&edition=fundamental","pubTime":"2026-03-14 00:31","pubTimestamp":1773419470,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings (TVGN) 近日披露了其人工智能平台 Predictcell™ Beta 版本的多项重要进展。该版本在精准度指标上展现出显著优化,同时公司还进一步扩展了其专有的AI基础设施架构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"1123137439","title":"Tevogen Bio Holdings 評估收購 Sciometrix 及 Clinicus 平台以監測長期新冠症狀","url":"https://stock-news.laohu8.com/highlight/detail?id=1123137439","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123137439?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 03:16","pubTimestamp":1773256571,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. 正在考虑收购 Sciometrix 和 Clinicus 平台,旨在加强对长期新冠(Long Covid)的监测能力。此举显示该公司正积极拓展其在生物科技领域的布局,特别是在应对新冠后遗症方面寻求新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2618118139","title":"Tevogen Bio Holdings Inc.盤中異動 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618118139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618118139?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 21:41","pubTimestamp":1773236461,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日21时41分,Tevogen Bio Holdings Inc.股票出现波动,股价快速跳水5.01%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.35%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311214101a6b84e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311214101a6b84e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"1135990684","title":"Tevogen推進仿製藥戰略,簽署意向書評估收購Apozeal製藥的潛在可能","url":"https://stock-news.laohu8.com/highlight/detail?id=1135990684","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135990684?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 03:51","pubTimestamp":1772740289,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings(简称Tevogen)近日在仿制药业务布局上迈出关键一步,公司已签署意向书,正式启动对Apozeal制药的潜在收购评估。此举标志着Tevogen正加速拓展其仿制药产品线,以强化在生物医药领域的市场竞争力。通过本次战略评估,Tevogen有望进一步整合行业资源,提升其在全球仿制药市场的份额。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"1146346246","title":"Tevogen Bio Holdings Inc 正積極考慮其他交易,重點聚焦生命科學相關業務","url":"https://stock-news.laohu8.com/highlight/detail?id=1146346246","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146346246?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 03:51","pubTimestamp":1772740274,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc 目前正积极评估其他交易机会,并将战略重点明确锁定在生命科学领域的相关业务上。公司此举旨在进一步拓展其在生物科技行业的影响力,并探索潜在的协同增长机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2614284430","title":"BUZZ-Tevogen因計劃收購數字醫療公司Sciometrix多數股權而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2614284430","media":"路透中文","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614284430?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 22:35","pubTimestamp":1772116522,"startTime":"0","endTime":"0","summary":"BUZZ-Tevogen因计划收购数字医疗公司Sciometrix多数股权而上涨2月26日 - ** 药物开发商Tevogen Bio TVGN.O股价盘前上涨13.7%至33美分** 公司签署了收购Sciometrix多数股权的意向书;如果交易成功,Tevogen将获得Clinicus数字医疗平台和远程监控工具的使用权** 称Sciometrix的技术可帮助Tevogen创收,支持基于价值的医疗服务,并加快药物开发速度** 财务条款未披露;交易取决于尽职调查、进一步谈判和监管部门的批准 - Tevogen ** 2025 年 TVGN 股价下跌约 68%(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL4S3ZM1H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"1106152731","title":"Tevogen Bio Holdings簽署意向書 擬評估收購Sciometrix及其數字護理管理平台Clinicus","url":"https://stock-news.laohu8.com/highlight/detail?id=1106152731","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106152731?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 22:20","pubTimestamp":1772115616,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings已签署意向书,正就潜在收购医疗科技公司Sciometrix及其创新数字护理管理平台Clinicus展开评估。此次战略举措旨在整合Clinicus的智能化患者管理技术,强化Tevogen在精准医疗领域的数字化服务能力。\n该平台通过人工智能驱动的远程监测系统,可实现个性化治疗方案的动态优化。若交易顺利完成,将显著提升Tevogen在细胞疗法商业化过程中的患者全周期管理效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2612259751","title":"Tevogen Bio Holdings Inc.盤中異動 股價大漲6.06%報0.294美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612259751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612259751?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 00:20","pubTimestamp":1771518007,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日00时20分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅拉升6.06%。截至发稿,该股报0.294美元/股,成交量26.4044万股,换手率0.13%,振幅5.38%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220002007a4b3d280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220002007a4b3d280&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2606786226","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌5.20%報0.332美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606786226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606786226?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 23:58","pubTimestamp":1769443133,"startTime":"0","endTime":"0","summary":"北京时间2026年01月26日23时58分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅跳水5.20%。截至发稿,该股报0.332美元/股,成交量7.9391万股,换手率0.04%,振幅4.77%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.49%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126235853a6af01f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126235853a6af01f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2584941954","title":"Tevogen Bio Holdings Inc.盤中異動 快速上漲6.10%報0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584941954?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 22:34","pubTimestamp":1763476478,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时34分,Tevogen Bio Holdings Inc.股票出现波动,股价急速上涨6.10%。截至发稿,该股报0.411美元/股,成交量5.7367万股,换手率0.03%,振幅3.95%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223438a70225ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223438a70225ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"1141099932","title":"Tevogen宣佈重大臨床里程碑:擴展其針對急性和長期新冠的精準T細胞治療的HLA覆蓋範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=1141099932","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141099932?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 04:20","pubTimestamp":1762374032,"startTime":"0","endTime":"0","summary":"Tevogen宣布重大临床里程碑:扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2581834794","title":"Tevogen Bio Holdings Inc.盤中異動 下午盤急速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834794?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 03:09","pubTimestamp":1762283362,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时09分,Tevogen Bio Holdings Inc.股票出现波动,股价快速下跌5.44%。截至发稿,该股报0.556美元/股,成交量26.711万股,换手率0.14%,振幅5.71%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503092297540342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503092297540342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"1101875233","title":"Tevogen計劃與政府倡議、長期新冠患者組織及醫療服務提供者合作,加快Tvgn 489的開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1101875233","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101875233?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 03:55","pubTimestamp":1760558109,"startTime":"0","endTime":"0","summary":"Tevogen计划与政府倡议、长期新冠患者组织及医疗服务提供者合作,加快Tvgn 489的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2572665597","title":"Tevogen Bio Holdings Inc.盤中異動 快速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572665597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572665597?lang=zh_tw&edition=fundamental","pubTime":"2025-10-03 22:08","pubTimestamp":1759500498,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日22时08分,Tevogen Bio Holdings Inc.股票出现异动,股价急速下跌5.39%。截至发稿,该股报0.737美元/股,成交量15.9692万股,换手率0.08%,振幅6.16%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003220818a4526c16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003220818a4526c16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}